MediPharm Labs (LABS) Stock Price, News & Analysis

Company Overview

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.

Key Stats

• Today's Range: C$0.07 to C$0.07
• 50-Day Range: C$0.07 to C$0.10
• 52-Week Range: C$0.06 to C$0.12
• Volume: 31,269 shs
• Average Volume: 307,295 shs
• Market Capitalization: C$29.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LABS Stock Analysis - Frequently Asked Questions

How have LABS shares performed this year?

MediPharm Labs' stock was trading at C$0.06 on January 1st, 2025. Since then, LABS stock has increased by 16.7% and is now trading at C$0.07.

How do I buy shares of MediPharm Labs?

Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of MediPharm Labs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), MediPharm Labs (MEDIF), BlackBerry (BB), HEXO (HEXO), Lightspeed Commerce (LSPD) and Organigram Global (OGI).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:LABS
• CIK: N/A
• Web: www.medipharmlabs.com
• Phone: 705 719 7425
• Fax: N/A
• Employees: 130
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$12.05 million
• Net Margins: -30.56%
• Pretax Margin: N/A
• Return on Equity: -24.41%
• Return on Assets: -7.17%

Debt

• Debt-to-Equity Ratio: 1.45
• Current Ratio: 3.21
• Quick Ratio: 3.10

Sales & Book Value

• Annual Sales: C$39.42 million
• Price / Sales: 0.74
• Cash Flow: C$0.05 per share
• Price / Cash Flow: 1.30
• Book Value: C$0.11 per share
• Price / Book: 0.64

Miscellaneous

• Outstanding Shares: 414,999,000
• Free Float: N/A
• Market Cap: C$29.05 million
• Optionable: Not Optionable
• Beta: 0.88